N. Murray

1.1k total citations
25 papers, 536 citations indexed

About

N. Murray is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, N. Murray has authored 25 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in N. Murray's work include Neuroscience of respiration and sleep (4 papers), Breast Cancer Treatment Studies (4 papers) and Obstructive Sleep Apnea Research (3 papers). N. Murray is often cited by papers focused on Neuroscience of respiration and sleep (4 papers), Breast Cancer Treatment Studies (4 papers) and Obstructive Sleep Apnea Research (3 papers). N. Murray collaborates with scholars based in United Kingdom, Australia and United States. N. Murray's co-authors include Peter Barrett‐Lee, Michael J. Browning, Walter F. Bodmer, J. Michael Dixon, Carlo Palmieri, Alison Jones, Chris Plummer, Andrew Stanley, C. Farrell and Renaud Léonard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

N. Murray

24 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Murray United Kingdom 11 199 182 145 80 76 25 536
Lynda M. Cristiano United States 9 108 0.5× 103 0.6× 24 0.2× 38 0.5× 165 2.2× 19 541
Matthew Pugh United Kingdom 13 119 0.6× 73 0.4× 35 0.2× 49 0.6× 70 0.9× 29 328
Arik Bernard Schulze Germany 14 163 0.8× 68 0.4× 49 0.3× 152 1.9× 32 0.4× 36 482
C. M. Doerschuk United States 9 71 0.4× 137 0.8× 16 0.1× 174 2.2× 16 0.2× 12 451
Jonathan Lambert United Kingdom 12 122 0.6× 32 0.2× 58 0.4× 48 0.6× 143 1.9× 28 476
Aikaterini Thanou United States 14 90 0.5× 307 1.7× 38 0.3× 10 0.1× 80 1.1× 23 581
A R Turnbull United Kingdom 11 91 0.5× 70 0.4× 10 0.1× 110 1.4× 45 0.6× 33 390
José Carlos Martínez Ávila Spain 11 171 0.9× 54 0.3× 19 0.1× 68 0.8× 43 0.6× 33 546
Ying Q. Lin China 10 69 0.3× 65 0.4× 19 0.1× 118 1.5× 31 0.4× 20 473
Alice A. Bickerstaff United States 13 71 0.4× 286 1.6× 40 0.3× 21 0.3× 23 0.3× 23 643

Countries citing papers authored by N. Murray

Since Specialization
Citations

This map shows the geographic impact of N. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Murray more than expected).

Fields of papers citing papers by N. Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Murray. The network helps show where N. Murray may publish in the future.

Co-authorship network of co-authors of N. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of N. Murray. A scholar is included among the top collaborators of N. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Murray. N. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sjoquist, Katrin Marie, Alexander Dobrovic, Kristy Robledo, et al.. (2023). Olaparib in HR-deficient (HRD), metastatic triple-negative breast cancer (TNBC) and relapsed ovarian cancer (ROC) without germline mutations in BRCA1 or BRCA2: Phase 2 EMBRACE trial.. Journal of Clinical Oncology. 41(16_suppl). e15079–e15079. 2 indexed citations
2.
Murray, N., Prudence A. Francis, Nicholas Zdenkowski, et al.. (2022). 91MO Randomized trial of neoadjuvant chemotherapy with or without concurrent aromatase inhibitor therapy to downstage ER+ve breast cancer: Breast Cancer Trials Group ANZ 1401 ELIMINATE trial. Annals of Oncology. 33. S164–S165. 2 indexed citations
3.
Minard‐Colin, Véronique, Birgit Burkhardt, Shannon L. Maude, et al.. (2019). BIANCA: A PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF TISAGENLECLEUCEL IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA. Hematological Oncology. 37(S2). 558–559. 1 indexed citations
4.
Murray, N., David K. McKenzie, Simon C. Gandevia, & Jane E. Butler. (2012). Effect of airway inflammation on short-latency reflex inhibition to inspiratory loading in human scalene muscles. Respiratory Physiology & Neurobiology. 181(2). 148–153. 7 indexed citations
5.
Earl, Helena, David Cameron, JMS Bartlett, et al.. (2012). Abstract OT3-3-09: ARTemis trial - randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer. Cancer Research. 72(24_Supplement). OT3–3.
6.
Flower, Oliver, et al.. (2012). Respiratory care of patients with cervical spinal cord injury: a review. Critical Care and Resuscitation. 14(1). 64–73. 28 indexed citations
7.
Petersen, N., Janet L. Taylor, N. Murray, Simon C. Gandevia, & Jane E. Butler. (2010). Differential effects of low-intensity motor cortical stimulation on the inspiratory activity in scalene muscles during voluntary and involuntary breathing. Respiratory Physiology & Neurobiology. 175(2). 265–271. 17 indexed citations
8.
Murray, N., David K. McKenzie, Simon C. Gandevia, & Jane E. Butler. (2010). Voluntary and involuntary ventilation do not alter the human inspiratory muscle loading reflex. Journal of Applied Physiology. 109(1). 87–94. 9 indexed citations
9.
Murray, N., et al.. (2009). Diagnosis and treatment of advanced breast cancer: summary of NICE guidance. BMJ. 338(feb25 1). b509–b509. 7 indexed citations
10.
Barrett‐Lee, Peter, J. Michael Dixon, C. Farrell, et al.. (2009). Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Annals of Oncology. 20(5). 816–827. 138 indexed citations
11.
Murray, N., David K. McKenzie, Robert B. Gorman, Simon C. Gandevia, & Jane E. Butler. (2008). Reproducibility of the short-latency reflex inhibition to loading of human inspiratory muscles. Respiratory Physiology & Neurobiology. 162(3). 216–222. 19 indexed citations
12.
Barrett‐Lee, Peter & N. Murray. (2006). Zoledronic acid versus ibandronate comparative evaluation in breast cancer patients with bone metastases: The NCRI zice trial. Bone. 38(3). 67–67. 9 indexed citations
13.
Murray, N., et al.. (2001). 'Puffer-PCA device' for rheumatoid arthritis patients. Anaesthesia. 56(6). 601–602. 1 indexed citations
14.
Browning, Michael J., Fiorella Petronzelli, D C Bicknell, et al.. (1996). Mechanisms of loss of HLA class I expression on colorectal tumor cells. Tissue Antigens. 47(5). 364–371. 89 indexed citations
15.
Braud, Véronique M., et al.. (1996). Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes.. Proceedings of the National Academy of Sciences. 93(1). 236–240. 26 indexed citations
16.
Kelley, Michael J., Kazuhiko Nakagawa, Nicholas K. Conrad, et al.. (1996). Genetic analysis of second primary lung cancers in patients surviving small cell lung cancer.. PubMed. 2(7). 1103–5. 5 indexed citations
17.
Hill, Ann B., John S. Haurum, N. Murray, et al.. (1995). Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.. The Journal of Experimental Medicine. 181(6). 2221–2228. 81 indexed citations
18.
Osoba, David, et al.. (1994). Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy.. PubMed. 8(3). 43–9; discussion 49. 6 indexed citations
19.
Murray, N. & A McMichael. (1992). Antigen presentation in virus infection. Current Opinion in Immunology. 4(4). 401–407. 25 indexed citations
20.
Murray, N., Jennifer Lyons, & Mark C. Chappell. (1986). Crescentic glomerulonephritis: a possible complication of streptokinase treatment for myocardial infarction.. Heart. 56(5). 483–485. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynda M. Cristiano Breakdown of academic impact, for papers by Matthew Pugh Breakdown of academic impact, for papers by Arik Bernard Schulze Breakdown of academic impact, for papers by C. M. Doerschuk Breakdown of academic impact, for papers by Jonathan Lambert Breakdown of academic impact, for papers by Aikaterini Thanou Breakdown of academic impact, for papers by A R Turnbull Breakdown of academic impact, for papers by José Carlos Martínez Ávila Breakdown of academic impact, for papers by Ying Q. Lin Breakdown of academic impact, for papers by Alice A. Bickerstaff
Rankless by CCL
2026